The Global Alzheimer’s Platform Foundation Network (GAP-Net) is an organization designed to accelerate Alzheimer’s and dementia clinical trials through standardized infrastructure and operational support.
GAP-Net focuses on improving site readiness, recruitment performance, and protocol consistency across participating networks. Centralized processes can reduce startup time and operational variability, which are common challenges in neurodegenerative disease trials. Participation supports efficient execution while maintaining oversight expectations for consent, monitoring, and safety reporting. Standardization can improve data quality and trial reliability in complex, long-duration studies.